other
confidence high
sentiment neutral
materiality 0.10
Nautilus Biotechnology holds 2023 annual meeting; reelects three Class II directors
Nautilus Biotechnology, Inc.
- Stockholders elected Parag Mallick, Matthew McIlwain, and Farzad Nazem as Class II directors with >92M votes for each.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023 with 108.8M votes for, 299k against.
- Approximately 109.2M shares represented out of 124.9M outstanding as of April 17, 2023.
- No other business items or significant developments reported.